At, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations. Outset Medical, Inc., 22-cv-04016.ĬlaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. The case is Plymouth County Retirement Association v. On this news, shares of Outset fell another 33%, from a closing price of $20.41 per share on June 13, 2022, to a closing price of $13.46 per share on June 14, 2022. The Company subsequently disclosed that the “ship hold” had been in place for weeks before investors were informed and that as a result of the hold, the Company was “suspending our prior full-year and long-term guidance.”. Then, on June 13, 2022, the Company disclosed a hold on all shipments of Tablo for home use by the FDA until proper regulatory clearance was received. On this news, shares of Outset fell more than 40% over the three trading days that followed, from a closing price of $39.94 per share on May 4, 2022, to a closing price of $23.06 per share on May 9, 2022. On May 5, 2022, the Company disclosed negative results for 1Q2022, which, among other things, analysts attributed to the untested nature of Tablo, its flagship product which is a dialysis machine that purifies tap water and then artificially purifies and removes toxins from the blood of patients suffering from kidney failure. Outset and certain of its executives are charged ith failing to disclose material information during the Class Period, violating federal securities laws. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.ĬareDx and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
Outset investors should visit us at or call toll-free (844) 367-9658. This action is pending in the United States District Court for the Northern District of California. (“Outset” or the “Company”) (NasdaqGS: OM), if they purchased the Company’s shares between Septemand June 13, 2022, inclusive (the “Class Period”). (Nasdaq: OM) (Outset) announced today that the Strategic Acquisition Center (SAC) Office of Procurement, Department of Veterans Affairs awarded a national contract that enables the company’s Tablo Hemodialysis System to be sold into the 106 VA hospitals in the U.S. 16, 2022 (GLOBE NEWSWIRE) - ClaimsFiler, a FREE shareholder information service, reminds investors that they have until Septemto file lead plaintiff applications in a securities class action lawsuit against Outset Medical, Inc.
0 kommentar(er)
